These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7685368)

  • 1. Antibodies developing against a single recombinant interferon protein may neutralize many other interferon-alpha subtypes.
    Brand CM; Leadbeater L; Bellati G; Marotta F; Ideo G
    J Interferon Res; 1993 Apr; 13(2):121-5. PubMed ID: 7685368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha neutralizing antibodies in HIV and chronic HCV patients treated with natural-source human leukocyte-derived interferon-alpha n3.
    Zhao XX; Hua J; Smith T; Ferencz-Biro K; Liao MJ; Rashidbaigi A
    Hum Antibodies; 1997; 8(3):129-36. PubMed ID: 9322083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.
    Ross C; Svenson M; Hansen MB; Vejlsgaard GL; Bendtzen K
    J Clin Invest; 1995 May; 95(5):1974-8. PubMed ID: 7738163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations.
    Antonelli G; Currenti M; Turriziani O; Dianzani F
    J Infect Dis; 1991 Apr; 163(4):882-5. PubMed ID: 1901335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to recombinant alpha interferon therapy in idiopathic mixed cryoglobulinemia: reinduction of remission by natural alpha interferon both in antibody-positive and -negative patients.
    Casato M; Antonelli G; Maggi F; Pucillo LP; Di Lullo L; Leoni M; Currenti M; Dianzani F; Bonomo L
    J Biol Regul Homeost Agents; 1994; 8(2):56-9. PubMed ID: 7863814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection.
    Milella M; Antonelli G; Santantonio T; Currenti M; Monno L; Mariano N; Angarano G; Dianzani F; Pastore G
    Liver; 1993 Jun; 13(3):146-50. PubMed ID: 8336526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-alpha.
    Jorns C; Holzinger D; Thimme R; Spangenberg HC; Weidmann M; Rasenack J; Blum HE; Haller O; Kochs G
    J Med Virol; 2006 Jan; 78(1):74-82. PubMed ID: 16299717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic hepatitis C with recombinant human interferon-alpha 2a: results of a randomized controlled clinical trial.
    Diodati G; Bonetti P; Noventa F; Casarin C; Rugge M; Scaccabarozzi S; Tagger A; Pollice L; Tremolada F; Davite C
    Hepatology; 1994 Jan; 19(1):1-5. PubMed ID: 7506223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of anti-interferon-alpha antibodies appearing during recombinant interferon-alpha 2a treatment.
    Rönnblom LE; Janson ET; Perers A; Oberg KE; Alm GV
    Clin Exp Immunol; 1992 Sep; 89(3):330-5. PubMed ID: 1516252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of anti-recombinant interferon-alpha 2 antibody positive CML patients with natural interferon-alpha.
    Wussow PV; Jakschies D; Freund M; Hehlmann R; Brockhaus F; Hochkeppel H; Horisberger M; Deicher H
    Br J Haematol; 1991 Jun; 78(2):210-6. PubMed ID: 2064959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitopes recognized by neutralizing therapy-induced human anti-interferon-alpha antibodies are localized within the N-terminal functional domain of recombinant interferon-alpha 2.
    Nolte KU; Günther G; von Wussow P
    Eur J Immunol; 1996 Sep; 26(9):2155-9. PubMed ID: 8814261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic characterization of recombinant, lymphoblastoid, and leukocyte IFN-alpha by monoclonal antibodies.
    Viscomi GC; Antonelli G; Bruno C; Scapol L; Malavasi F; Funaro A; Simeoni E; Pestka S; De Pisa F; Dianzani F
    J Interferon Cytokine Res; 1999 Apr; 19(4):319-26. PubMed ID: 10334382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful re-treatment of an anti-interferon resistant polycythaemia vera patient with lymphoblastoid interferon-alpha N1 and in vitro studies on the specificity of the antibodies.
    Brand CM; Leadbeater L; Budiman R; Lechner K; Gisslinger H
    Br J Haematol; 1994 Jan; 86(1):216-8. PubMed ID: 8011536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum interferon (IFN)-neutralizing antibodies and bioactivities of IFNs in patients with severe type II essential mixed cryoglobulinemia.
    Scagnolari C; Casato M; Bellomi F; De Pisa F; Turriziani O; Coviello R; Pirro MR; Dianzani F; Antonelli G
    Clin Diagn Lab Immunol; 2003 Jan; 10(1):70-7. PubMed ID: 12522042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha antibodies in patients with renal cell carcinoma treated with recombinant interferon-alpha-2A in an adjuvant multicenter trial. The Delta-P Study Group.
    Prümmer O
    Cancer; 1993 Mar; 71(5):1828-34. PubMed ID: 8448744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with natural IFN of hepatitis C patients with or without antibodies to recombinant IFN.
    Milella M; Antonelli G; Santantonio T; Giannelli G; Currenti M; Monno L; Turriziani O; Pastore G; Dianzani F
    Hepatogastroenterology; 1995 Jul; 42(3):201-4. PubMed ID: 7590565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-alpha antibodies in patients with age-related macular degeneration treated with recombinant human IFN-alpha2a.
    Ross C; Engler CB; Sander B; Bendtzen K
    J Interferon Cytokine Res; 2002 Apr; 22(4):421-6. PubMed ID: 12034024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
    Sakashita H
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interferon-alpha 2b gene in Japanese patients with chronic viral hepatitis who developed antibodies after treatment with recombinant interferon-alpha 2a.
    Hosoi H; Imai M; Yamanaka M
    J Gastroenterol Hepatol; 1992; 7(4):411-6. PubMed ID: 1515568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.